Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

120 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Design of a Glycoconjugate Vaccine Against Salmonella Paratyphi A.
Alfini R, Carducci M, Massai L, De Simone D, Mariti M, Rossi O, Rondini S, Micoli F, Giannelli C. Alfini R, et al. Among authors: micoli f. Vaccines (Basel). 2024 Nov 12;12(11):1272. doi: 10.3390/vaccines12111272. Vaccines (Basel). 2024. PMID: 39591175 Free PMC article.
Adjuvanted Modified Bacterial Antigens for Single-Dose Vaccines.
Di Benedetto R, Massai L, Wright M, Mancini F, Cleveland M, Rossi O, Giannelli C, Berlanda Scorza F, Micoli F. Di Benedetto R, et al. Among authors: micoli f. Int J Mol Sci. 2024 Oct 25;25(21):11461. doi: 10.3390/ijms252111461. Int J Mol Sci. 2024. PMID: 39519015 Free PMC article.
Modeling 1-Cyano-4-Dimethylaminopyridine Tetrafluoroborate (CDAP) Chemistry to Design Glycoconjugate Vaccines with Desired Structural and Immunological Characteristics.
Nappini R, Alfini R, Durante S, Salvini L, Raso MM, Palmieri E, Di Benedetto R, Carducci M, Rossi O, Cescutti P, Micoli F, Giannelli C. Nappini R, et al. Among authors: micoli f. Vaccines (Basel). 2024 Jun 24;12(7):707. doi: 10.3390/vaccines12070707. Vaccines (Basel). 2024. PMID: 39066345 Free PMC article.
Safety and Immunogenicity of a 4-Component Generalized Modules for Membrane Antigens Shigella Vaccine in Healthy European Adults: Randomized, Phase 1/2 Study.
Leroux-Roels I, Maes C, Mancini F, Jacobs B, Sarakinou E, Alhatemi A, Joye J, Grappi S, Cilio GL, Serry-Bangura A, Vitali CG, Ferruzzi P, Marchetti E, Necchi F, Rappuoli R, De Ryck I, Auerbach J, Colucci AM, Rossi O, Conti V, Scorza FB, Arora AK, Micoli F, Podda A, Nakakana UN; Shigella Project Team. Leroux-Roels I, et al. Among authors: micoli f. J Infect Dis. 2024 Oct 16;230(4):e971-e984. doi: 10.1093/infdis/jiae273. J Infect Dis. 2024. PMID: 38853614 Free PMC article. Clinical Trial.
Development of a visual Adhesion/Invasion Inhibition Assay to assess the functionality of Shigella-specific antibodies.
Batani G, Vezzani G, Lashchuk S, Allaoui A, Cardamone D, Raso MM, Boero E, Roscioli E, Ridelfi M, Gasperini G, Pizza M, Rossi O, Berlanda Scorza F, Micoli F, Rappuoli R, Sala C. Batani G, et al. Among authors: micoli f. Front Immunol. 2024 Apr 12;15:1374293. doi: 10.3389/fimmu.2024.1374293. eCollection 2024. Front Immunol. 2024. PMID: 38680489 Free PMC article.
120 results